Dyslipidemia prevalence, treatment and control in a multiethnic population
Rebecca Ireland
This article has no abstract so we have provided the first paragraph of the full text.
Treating dyslipidemia can lower the risk of coronary heart disease. The National Cholesterol Education Program's third report of the Adult Treatment Panel (ATP III) makes recommendations to health-care professionals regarding the diagnosis and treatment of dyslipidemia. The Multi-Ethnic Study of Atherosclerosis (MESA) investigated the prevalence and treatment of dyslipidemia in a cohort of healthy individuals to assess the challenges facing implementation of these guidelines.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
